|
1
|
Kumarasamy KK, Toleman MA, Walsh TR,
Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske
CG, Irfan S, et al: Emergence of a new antibiotic resistance
mechanism in India, Pakistan, and the UK A molecular, biological,
and epidemiological study. Lancet Infect Dis. 10:597–602. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barbier F, Pommier C, Garrouste-Orgeas M,
Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h
C, Darmon M, et al: Extended-spectrum beta-lactamase-producing
Enterobacteriaceae in critically iii patients: Impact of carriage
and infection on carbapenem consumption, duration of Icu stay, and
mortality. Intensive Care Med Exp. 3 Suppl 1:A12015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mushtaq S, Woodford N, Hope R, Adkin R and
Livermore DM: Activity of BAL30072 alone or combined with
β-lactamase inhibitors or with meropenem against
carbapenem-resistant Enterobacteriaceae and non-fermenters. J
Antimicrob Chemother. 68:1601–1608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nordmann P, Dortet L and Poirel L:
Carbapenem resistance in Enterobacteriaceae: Here is the storm!
Trends Mol Med. 18:1–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Satlin MJ, Chen L, Patel G, Gomez-Simmonds
A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG,
et al: Multicenter clinical and molecular epidemiological analysis
of bacteremia due to carbapenem-resistant enterobacteriaceae (CRE)
in the CRE epicenter of the United States. Antimicrob Agents
Chemother. 61:pii: e02349–16. 2017. View Article : Google Scholar
|
|
6
|
Blair JM, Webber MA, Baylay AJ, Ogbolu DO
and Piddock LJ: Molecular mechanisms of antibiotic resistance. Nat
Rev Microbiol. 13:42–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R,
Spencer J, Doi Y, Tian G, Dong B, Huang X, et al: Emergence of
plasmid-mediated colistin resistance mechanism MCR-1 in animals and
human beings in China: A microbiological and molecular biological
study. Lancet Infect Dis. 16:161–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan AU, Maryam L and Zarrilli R:
Structure, genetics and worldwide spread of New Delhi
metallo-β-lactamase (NDM): A threat to public health. BMC
Microbiol. 17:1012017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Diene SM and Rolain JM: Carbapenemase
genes and genetic platforms in Gram-negative bacilli:
Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin
Microbiol Infect. 20:831–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vasoo S, Barreto JN and Tosh PK: Emerging
issues in gram-negative bacterial resistance: An update for the
practicing clinician. Mayo Clin Proc. 90:pp. 395–403. 2015;
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brust K, Evans A and Plemmons R:
Favourable outcome in the treatment of carbapenem-resistant
Enterobacteriaceae urinary tract infection with high-dose
tigecycline. J Antimicrob Chemother. 69:2875–2876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta N, Limbago BM, Patel JB and Kallen
AJ: Carbapenem-resistant Enterobacteriaceae: Epidemiology and
prevention. Clin Infect Dis. 53:60–67. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Surgers L, Boyd A, Boelle PY, Lalande V,
Jolivot PA, Girard PM, Arlet G, Cambier C, Homor A, Decre D and
Meynard JL: Clinical and microbiological determinants of severe and
fatal outcomes in patients infected with Enterobacteriaceae
producing extended-spectrum β-lactamase. Eur J Clin Microbiol
Infect Dis. 36:1261–1268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paul M, Carmeli Y, Durante-Mangoni E,
Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C and Leibovici
L: Combination therapy for carbapenem-resistant Gram-negative
bacteria. J Antimicrob Chemother. 69:2305–2309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steinmann J, Kaase M, Gatermann S, Popp W,
Steinmann E, Damman M, Paul A, Saner F, Buer J and Rath P: Outbreak
due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in
a German university hospital, July 2010 to January 2011. Euro
Surveill. 16:pii: 199442011.
|
|
16
|
Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D
and Zhang Y: Emergence of carbapenem-resistant clinical
Enterobacteriaceae isolates from a teaching hospital in Shanghai,
China. J Med Microbiol. 61:132–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ho PL, Lo WU, Yeung MK, Lin CH, Chow KH,
Ang I, Tong AH, Bao JY, Lok S and Lo JY: Complete sequencing of
pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant
Escherichia coli strain isolated in Hong Kong. PLoS One.
6:e179892011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Q, Wang H, Sun H, Chen H, Xu Y and
Chen M: Phenotypic and genotypic characterization of
Enterobacteriaceae with decreased susceptibility to carbapenems:
Results from large hospital-based surveillance studies in China.
Antimicrob Agents Chemother. 54:573–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JY, Hong YK, Lee H and Ko KS: High
prevalence of non-clonal imipenem-nonsusceptible Enterobacter spp.
isolates in Korea and their association with porin down-regulation.
Diagn Microbiol Infect Dis. 87:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
